NBP258874PE

Novus Biologicals™ p21/CIP1/CDKN1A Recombinant Protein Antigen

Manufacturer: Novus Biologicals™

Select a Size

Pack Size SKU Availability Price
Each of 1 NBP258874PE-Each-of-1 In Stock ₹ 31,372.50

NBP258874PE - Each of 1

₹ 31,372.50

In Stock

Quantity

1

Base Price: ₹ 31,372.50

GST (18%): ₹ 5,647.05

Total Price: ₹ 37,019.55

Gene ID (Entrez)

1026

Common Name

p21/CIP1/CDKN1A Recombinant Protein Antigen

Formulation

PBS and 1M Urea, pH 7.4.

Gene Alias

CAP20cyclin-dependent kinase inhibitor 1, CDK-interacting protein 1, CDKN1melanoma differentiation associated protein 6, CIP1WAF1CDK-interaction protein 1, cyclin-dependent kinase inhibitor 1A (p21, Cip1), MDA6, MDA-6, Melanoma differentiation-associated

Label Type

Unlabeled

Quantity

100μL

Source

E.coli

Purification Method

>80% by SDS-PAGE and Coomassie blue staining

Content And Storage

Store at −20°C. Avoid freeze-thaw cycles.

For Use With (Application)

Blocking/Neutralizing, Control

Gene Symbol

CDKN1A

Product Type

Recombinant Protein Antigen

Regulatory Status

RUO

Specific Reactivity

This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-51052. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml

Related Products

Img

Novus Biologicals™

NBP258725PE

--

Img

Novus Biologicals™

NBP258809PE

--

Img

Novus Biologicals™

NBP258470PE

--

Img

Novus Biologicals™

NBP258356PE

--

Img

Novus Biologicals™

NBP258609PE

--

Img

Novus Biologicals™

NBP258217PE

--

Img

Novus Biologicals™

NBP258664PE

--

Img

Novus Biologicals™

NBP258542PE

--

Description

  • A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human p21/CIP1/CDKN1A
  • Source: E.coli Amino Acid Sequence: ARERWNFDFVTETPLEGDFAWERVRGLGLPKLYLPTGPRRGRDELGGGRRPGTSPALLQGTAEEDHVDLSLSCTLVPRSGEQAEGSPGGPGDSQGRKRRQTSMTDFYHSKR The p21/CIP1/CDKN1A Recombinant Protein Antigen is derived from E
  • coli
  • The p21/CIP1/CDKN1A Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.